| Financial Year |
March 31 2023 |
| Monetary Funds |
502,176,312.51 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
79,999,089.30 |
| Accounts Receivable |
478,067,983.68 |
| Advances to Suppliers |
6,583,469.60 |
| Other Receivables |
13,621,318.10 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
270,353,599.04 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
22,148,826.30 |
| Total Current Assets |
1,473,176,237.95 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
426,280,053.77 |
| Under-construction Projects |
6,259,266.53 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
78,001,158.24 |
| R&D expenses |
-- |
| Goodwill |
7,432,203.43 |
| Long-Term Deferred and Prepaid Expenses |
6,483,055.96 |
| Deferred Income Tax Assets |
11,029,170.17 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
573,960,571.10 |
| Total Assets |
2,047,136,809.05 |
| Short-Term Loans |
51,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
211,648,040.90 |
| Accounts Payable |
525,627,975.81 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
25,751,704.94 |
| Taxes Payable |
10,442,616.32 |
| Interest Payable |
-- |
| Dividend Payable |
812,550.00 |
| Other payables |
46,002,243.95 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
10,339,941.05 |
| Other Current Liabilities |
8,091,034.54 |
| Sub-Total of Current Liabilities |
891,649,133.78 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
3,157,599.22 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
34,012,398.93 |
| Total Liabilities |
925,661,532.71 |
| Paid-In Capital(Or Share Stock) |
137,108,500.00 |
| Capital Surplus |
518,120,829.43 |
| Surplus Reserve |
64,070,261.85 |
| LESS:Treasury Stock |
32,258,235.00 |
| Undistributed Profits |
401,646,637.94 |
| Minority Stockholder's Interest |
32,614,622.67 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,088,860,653.67 |
| Owner's Equity（Stockholder's Equity） |
1,121,475,276.34 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,047,136,809.05 |
